Description
Tirzepatide is a breakthrough GLP-1 and GIP receptor agonist used to treat obesity and type 2 diabetes. This once-weekly injectable works by regulating insulin, suppressing appetite, and improving blood sugar control. With superior weight loss outcomes compared to other GLP-1 medications, Tirzepatide is ideal for patients pursuing effective body recomposition, metabolic health, and long-term fat reduction. The 5mg dose supports titration or maintenance therapy in medically supervised programs.
Key Clinical Benefits:
- Dual-action GLP-1 + GIP mechanism
- Promotes significant fat loss and appetite suppression
- Improves insulin sensitivity and blood glucose control
- Supports cardiovascular and metabolic health






